Johnson & Johnson (CHIX:JNJd) Stock News, Headlines & Updates
Johnson & Johnson Stock News from GuruFocus
- 1
- 2
- 3
- 4
- 5
Jul 23, 2025
Johnson & Johnson (JNJ) Gains EC Approval for New DARZALEX Faspro Use | JNJ Stock News
GuruFocus News • 11:00am
Johnson & Johnson (JNJ) Upgraded to Buy by Erste Group Analyst | JNJ Stock News
GuruFocus News • 7:53am
Jul 22, 2025
JNJ Expands ZILRETTA's Reach Through Strategic Partnership | JNJ Stock News
GuruFocus News • 7:20am
Jul 21, 2025
Johnson & Johnson (JNJ) Highlights Robotic Advancements in Orthopedics | JNJ Stock News
GuruFocus News • 2:15pm
Johnson & Johnson (JNJ) Seeks FDA Approval for Psoriasis Treatment
GuruFocus News • 8:57am
Johnson & Johnson Seeks FDA Approval for Icotrokinra, Aiming to Transform Psoriasis Treatment | JNJ stock news
GuruFocus News • 8:04am
Johnson & Johnson seeks first icotrokinra U.S. FDA approval aiming to revolutionize treatment paradigm for adults and adolescents with plaque psoriasis
PRNewswire • 8:00am
JNJ Submits Drug Application to FDA for Icotrokinra Approval | JNJ Stock News
GuruFocus News • 7:48am
Johnson & Johnson (JNJ) Seeks FDA Approval for Psoriasis Treatment | JNJ Stock News
GuruFocus News • 7:46am
Johnson & Johnson (JNJ) Seeks FDA Nod for New Psoriasis Treatment | JNJ Stock News
GuruFocus News • 7:20am
Johnson & Johnson seeks first icotrokinra U.S. FDA approval aiming to revolutionize treatment paradigm for adults and adolescents with plaque psoriasis | JNJ Stock News
GuruFocus News • 7:17am
Jul 20, 2025
Johnson & Johnson (JNJ) Raises Full-Year Forecast Amid Strong Performance
GuruFocus News • 8:55am
Jul 19, 2025
Insider Trading Alert: Johnson & Johnson (JNJ) Executive Sells Major Stake
GuruFocus News • 10:55am
Jul 18, 2025
Insider Sell: John Reed Sells Shares of Johnson & Johnson
GuruFocus News • 5:01pm
Jul 17, 2025
Johnson & Johnson (JNJ): Barclays Analyst Raises Price Target | JNJ Stock News
GuruFocus News • 10:32am
RBC Capital's Updated Price Target for JNJ Reaches $185 | JNJ Stock News
GuruFocus News • 9:32am
Guggenheim Raises Johnson & Johnson (JNJ) Price Target to $167 | JNJ Stock News
GuruFocus News • 9:00am
UBS Raises Price Target for Johnson & Johnson (JNJ) to $190 | JNJ Stock News
GuruFocus News • 8:37am
Johnson & Johnson Receives FDA Priority Review for TAR-200 NDA | JNJ stock news
GuruFocus News • 8:02am
Johnson & Johnson (JNJ) Target Price Raised by UBS | JNJ Stock News
GuruFocus News • 8:01am
Johnson & Johnson receives U.S. FDA Priority Review for TAR-200 NDA in high-risk non-muscle invasive bladder cancer
PRNewswire • 8:00am
Johnson & Johnson (JNJ) Receives FDA Priority Review for Bladder Cancer Drug
GuruFocus News • 7:57am
Guggenheim Adjusts Price Target for Johnson & Johnson (JNJ) Following Strong Q2 | JNJ Stock News
GuruFocus News • 7:30am
Johnson & Johnson receives U.S. FDA Priority Review for TAR-200 NDA in high-risk non-muscle invasive bladder cancer | JNJ Stock News
GuruFocus News • 7:21am
Johnson & Johnson (JNJ) Receives FDA Priority Review for New Bladder Cancer Treatment | JNJ Stock News
GuruFocus News • 7:16am
Johnson & Johnson (JNJ): Morgan Stanley Raises Price Target to $176 | JNJ Stock News
GuruFocus News • 7:02am
Johnson & Johnson (JNJ) Price Target Raised by B of A Securities | JNJ Stock News
GuruFocus News • 6:31am
Johnson & Johnson (JNJ) Sees Price Target Boost After Strong Q2 Performance | JNJ Stock News
GuruFocus News • 6:00am
Johnson & Johnson (JNJ) Q2 2025 Earnings Call Highlights: Strong Sales Growth Amid Challenges
GuruFocus News • 1:02am
Q2 2025 Johnson & Johnson Earnings Call Transcript
GuruFocus News • 11:01pm
Jul 16, 2025
JNJ Stock Rises on Strong Earnings and Upgraded Guidance
GuruFocus News • 1:50pm
Johnson & Johnson (JNJ) Trading 6.51% Higher on Jul 16
GuruFocus News • 12:03pm
Dean Omar Branham Shirley Attorney Named Among Nation's Top Future Legal Leaders | JNJ Stock News
GuruFocus News • 11:15am
Johnson & Johnson Reports Strong Q2 Results and Raises FY25 Guidance
GuruFocus News • 11:14am
Johnson & Johnson (JNJ) Surges After Outperforming Q2 Estimates
GuruFocus News • 10:56am
Johnson & Johnson (JNJ)'s Winning Formula: Financial Metrics and Competitive Strengths
GuruFocus News • 10:03am
JNJ Reports Strong Growth in MedTech and Innovative Medicine | JNJ Stock News
GuruFocus News • 8:30am
Johnson & Johnson Q2 2025 Earnings: Revenue Surpasses Estimates at $23.7 Billion, EPS Falls Short at $2.29
GuruFocus News • 7:31am
Johnson & Johnson (JNJ) Outperforms with Strong Q2 Earnings, Raises 2025 Outlook
GuruFocus News • 6:58am
Johnson & Johnson Declares Third Quarter 2025 Dividend | JNJ stock news
GuruFocus News • 6:04am
- 1
- 2
- 3
- 4
- 5
Show
Entries
Headlines
Total 0- 1
No recent news